Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction. - Wikidata - awgldk - TriplyDB

Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction.

Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction.

http://www.wikidata.org/entity/Q44211387

about

Gene therapy for lower urinary tract dysfunction Stem cells for urinary tract regeneration Stem cell therapy in bladder dysfunction: where are we? And where do we have to go?Stem Cells: It's Good To Have Choices.Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells.Stem cells for the treatment of urinary incontinence.Stem cell transplantation for treating Duchenne muscular dystrophy: A Web of Science-based literature analysis Muscle-derived stem cells for tissue engineering and regenerative therapy.Basal Lamina Mimetic Nanofibrous Peptide Networks for Skeletal Myogenesis.Diagnosis and management of patients with overactive bladder syndrome and abnormal detrusor activity.Muscling in on stem cells.Coining a new term-Urovesicology: advancing towards a mechanistic understanding of bladder symptoms.Gene therapy used for tissue engineering applications.Sphincter contractility after muscle-derived stem cells autograft into the cryoinjured anal sphincters of rats Stem and endothelial progenitor cells in erection biology.Bioengineered tissues for urogenital repair in children.The clinical relevance of cell-based therapy for the treatment of stress urinary incontinence.Regeneration of skeletal muscle.Advanced therapeutic directions to treat the underactive bladder.Intrasphincteric autologous myoblast injections with electrical stimulation for stress urinary incontinence.Addressing challenges in underactive bladder: recommendations and insights from the Congress on Underactive Bladder (CURE-UAB).A tissue-engineered suburethral sling in an animal model of stress urinary incontinence.Intradetrusor injection of adult muscle-derived cells for the treatment of underactive bladder: pilot study.A novel method for differentiation of human mesenchymal stem cells into smooth muscle-like cells on clinically deliverable thermally induced phase separation microspheres.Dynamics of acute local inflammatory response after autologous transplantation of muscle-derived cells into the skeletal muscle.Pharmacological treatments available for the management of underactive bladder in neurological conditions.The potential of muscle-derived stem cells for stress urinary incontinence.Protective effect of sodium ascorbate on efficacy of intramuscular transplantation of autologous muscle-derived cells.Improvement of urethral sphincter deficiency in female rats following autologous skeletal muscle myoblasts grafting.Chitosan-gelatin sheets as scaffolds for muscle tissue engineering.Recent advances in the understanding and management of underactive bladder.

P2860

Q26824783-F4FFE394-F647-4030-AE4E-F21FFB9BFE97 Q26830507-EE0AE610-73E8-443A-AF7F-704FE5B354A2 Q26862700-9F21ACED-C02C-49FF-A8FE-E580497212D2 Q33572568-8E95C339-A155-4B6D-B935-5B0F60E2838B Q34479398-C9652C38-AA40-4A44-802B-5612F34E1A02 Q34491806-1C411ECB-891B-450A-A19C-DAE6F6B56B36 Q34997665-36692AB6-02C0-4C8B-B4A6-66B82EA66331 Q36171454-E4D86279-F389-4C86-AAC5-A1436F746A0A Q36265728-F78AA7EE-4F4F-4ED7-8709-A61B5D84AC2A Q36395035-A53434E7-C694-451C-A3BA-B594551F2E09 Q36424273-EBEBE8A6-2BD5-4966-98BB-814C97C13945 Q36463541-533CCEEA-6ED3-4239-B1AB-09FB2985D575 Q36748645-E0423227-AA7D-4290-A86C-CE3AB1999976 Q36839060-A76531BF-99DC-4219-9BBF-EB563181E49C Q37078842-CE4EE092-1EFF-43FF-BA08-3FDC66DD07ED Q37143948-38FF94EC-23A6-4AC7-9BE9-7E89A449228C Q37874640-9F5E2CB6-4884-4D13-839A-F551C9225AA0 Q37888538-5F3C3B81-05A0-435B-94CA-F9318CAA2CDF Q38252669-251377D0-FA8B-4398-B38B-28A160AC914C Q38475944-E3617CE5-7B91-48BA-BDF7-A625ADE6A2DC Q39148756-EC49D1C1-D531-42B0-9975-5E45DC36E4B2 Q40396566-2A2260CA-FBC8-430C-A659-4591ED625E96 Q41495249-2814786D-067C-4457-A7F5-3531D7644F51 Q41833608-B481ACC5-4AFC-440E-8676-B070952126D7 Q42876335-AA252C00-A0EC-482C-98BD-30D51141511E Q47802223-2B0D4E4A-9A13-4C8E-BDDF-98ECAD3FBCAD Q48557639-91719ECA-77EA-4917-8852-7414D6F68A9A Q50505656-BAFC4A7D-5F6D-400C-B22C-3435947D8C50 Q51727741-283C142D-6B22-42DF-AE56-758506DCFED0 Q53676677-4C1E6E52-F753-4CE8-AF4C-C11DEFAA55A5 Q55259311-75C0ACD2-A76F-400F-A140-D39BF0A0CBD7

P2860

Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction.

http://www.wikidata.org/entity/Q44211387

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction.

@en

Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction.

@nl

type

label

Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction.

@en

Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction.

@nl

prefLabel

Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction.

@en

Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction.

@nl

P1433

Q44211387-1CEB99F4-14CB-4082-85A5-8E10B8BA5A3F

P1476

Q44211387-D81EFDBC-AB43-4B33-AECE-BDF55A430B1E

P2093

Q44211387-23E98FF5-80EC-4CEF-82DC-4B071521418B

Q44211387-42069778-194C-4AAE-8BB5-253381279A81

Q44211387-4A839F3E-3C91-4031-9860-02BE4C3025D3

Q44211387-78FBD016-B628-4EC4-8E1C-B37C8B6633E2

Q44211387-85FDD0BC-C1AC-4F23-B249-2B7435AEF499

Q44211387-C9737597-D2EB-4612-89B3-2D228D360FA3

Q44211387-D211FAE7-9DFA-4118-9008-1A0691C10B3E

Q44211387-F07868FF-93BC-4D09-BD4D-3D35E0564ECD

Q44211387-F4D52E34-7287-49C5-B910-5B5CA4F9A1F7

P2860

Q44211387-02228D95-3D30-4E16-8E87-D28DEDE7B9FE

Q44211387-0E6B6097-0FC5-4C37-9338-4A35CF11AD9A

Q44211387-254C88C6-6441-469B-968C-CBDF50B698F4

Q44211387-57775837-8F89-4502-A0E7-0481DFAAF934

Q44211387-5A0A546B-0E93-481A-B405-951C6D22D265

Q44211387-5F8CBF58-7310-43A8-9AFD-106B101C2FE9

Q44211387-621547FD-5559-4D82-BC7C-EFAB5A23508D

Q44211387-8B220E35-9F4D-4ADA-8FC1-2ECA7AC90118

Q44211387-8B596617-77DC-437C-9913-25F62D8781DA

Q44211387-90A1F571-FA93-4A5B-B6DF-1EC838019DDC

P2888

Q44211387-D0BF3861-1B3B-4BB2-B3E8-AEC48BD0C991

P304

Q44211387-5199BB8D-2A6D-422B-AE61-4A49F38AF9FC

P31

Q44211387-00F0AEA4-86F5-4A5C-A45E-4A0EEFA6E2AD

P356

Q44211387-1BBDB4A4-A2CC-487E-9517-D2E6532FD690

P433

Q44211387-BA1944AC-2681-493D-BCAB-A3EDB5CA4A8C

P478

Q44211387-52B8242B-721A-4B0E-91FF-E8A3EE438741

P577

Q44211387-7A1B1BD2-5F64-4FD5-9EAC-9C05C6A474A6

P5875

Q44211387-1EAA0234-E6C2-4725-9694-1A1A2CBAF8D1

P6179

Q44211387-3A7F29A3-6CAA-4738-BAA5-F8DC0C2FEB26

P698

Q44211387-444E2AD0-37FC-48EC-83CF-55E3453CE1C0

P921

Q44211387-AA31F802-8481-4FDE-9E0F-B0D057ED550F

P356

P1433

P1476

Muscle-derived cell-mediated ex vivo gene therapy for urological dysfunction.

@en

P2093

Chancellor MB

http://www.w3.org/2001/XMLSchema#string

Huard J

http://www.w3.org/2001/XMLSchema#string

Lee JY

http://www.w3.org/2001/XMLSchema#string

Li Y

http://www.w3.org/2001/XMLSchema#string

Pruchnic R

http://www.w3.org/2001/XMLSchema#string

Qu Z

http://www.w3.org/2001/XMLSchema#string

Somogyi GT

http://www.w3.org/2001/XMLSchema#string

Yokoyama T

http://www.w3.org/2001/XMLSchema#string

de Groat WC

http://www.w3.org/2001/XMLSchema#string

P2860

The smooth muscle alpha-actin gene promoter is differentially regulated in smooth muscle versus non-smooth muscle cells.

Hematopoietic potential of stem cells isolated from murine skeletal muscle

Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage.

Development of approaches to improve cell survival in myoblast transfer therapy.

Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source.

Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration.

Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing.

Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy

Prevalence and risk factors of incontinence after stroke. The Copenhagen Stroke Study.

The fate of individual myoblasts after transplantation into muscles of DMD patients.

P2888

P304

1617-1626

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.GT.3301816

http://www.w3.org/2001/XMLSchema#string

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2002-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11041350

http://www.w3.org/2001/XMLSchema#string

P6179

1045179605

http://www.w3.org/2001/XMLSchema#string

P698

12424614

http://www.w3.org/2001/XMLSchema#string

P921